Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 1932

Sort by

Sort Order Select

Journal Articles

Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury

E. Bridget Kim, Jack E. Malespini, Matthew Lei, Samuel S. Han, Cole W. Minsky, Andrew R. Branagan, Elizabeth K. O’Donnell, Diana Cirstea, Noopur S. Raje, Andrew J. Yee

Blood Adv (2025) 9 (13): 3129–3135.

https://doi.org/10.1182/bloodadvances.2025015901

Published: 2025

Includes: Supplemental data

Journal Articles

Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females

Yohei Doi, Takayuki Hamano, Osamu Yamaguchi, Yoshitaka Isaka

Blood Adv (2025) 9 (13): 3202–3212.

https://doi.org/10.1182/bloodadvances.2025016320

Published: 2025

Includes: Supplemental data

Journal Articles

Immunological consequences of CAR T-cell therapy: an analysis of infectious complications and immune reconstitution

Andreas Riedel, Laurent Phely, Stefan Hug, Philipp Faustmann, Jan Christian Schroeder, Britta Besemer, Anna M. Paczulla Stanger, Christoph Faul, Claudia Lengerke, Jan Frederic Weller, Wolfgang Bethge

Blood Adv (2025) 9 (13): 3149–3158.

https://doi.org/10.1182/bloodadvances.2024015346

Published: 2025

Includes: Supplemental data

Journal Articles

Younger haplo-donors improve older patient survival outcomes

Ahmad Ghorab, Leo Luznik

Blood Adv (2025) 9 (13): 3308–3309.

https://doi.org/10.1182/bloodadvances.2025016335

Published: 2025

Journal Articles

Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes

Marek Trněný, Laura Fogliatto, Faithlore Gardner, Ian Flinn, Jean-François Larouche, Corinne Haioun, Miguel Canales, Hideki Goto, Roman Hajek, Gilles Salles, Avrita Singh, Mark Yan, Rucha Kothari, Gabriel Man, Deniz Sahin, Jamie Hirata, Calvin Lee, Hervé Tilly, Christopher R. Flowers

Blood Adv (2025) 9 (13): 3263–3267.

https://doi.org/10.1182/bloodadvances.2024014695

Published: 2025

Journal Articles

Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704

Blood Adv (2025) 9 (13): 3268–3280.

https://doi.org/10.1182/bloodadvances.2025015793

Published: 2025

Includes: Supplemental data

Journal Articles

Complement C5 inhibition in early onset HELLP syndrome

Gloria F. Gerber, Robert A. Brodsky, Arthur Jason Vaught

Blood Adv (2025) 9 (13): 3304–3307.

https://doi.org/10.1182/bloodadvances.2024014746

Published: 2025

Includes: Supplemental data

Journal Articles

Efficacy and Safety of BCMA Nanobody CAR-T Cell Therapy in Relapsed or Refractory Plasma Cell Myeloma

Xian Zhang, Lin Wang, Junfang Yang, Xiaona Hu, Hui Wang, Lina Zhang, Xiaoge Zhou, Ying Liu, Qinglong Wang, Peihua Lu

Blood Adv bloodadvances.2025016322.

https://doi.org/10.1182/bloodadvances.2025016322

Published: 2025

Includes: Supplemental data

Journal Articles

Evaluation of In vivo CAR Transgene Levels in Tisagenlecleucel-Treated Patients with Relapsed/Refractory B-ALL and DLBCL

Rakesh Awasthi, Stephan A. Grupp, Edward Waldron, Gregory A Yanik, Constantine S Tam, Susana Rives, Joseph P. McGuirk, Michael A. Pulsipher, Ulrich Jaeger, Gary Douglas Myers, Peter Borchmann, Stephen J. Schuster, Heather E Stefanski, Michael R Bishop, Abhijit Chakraborty, Aisha Masood, André Baruchel, Edmund K Waller

Blood Adv bloodadvances.2024014995.

https://doi.org/10.1182/bloodadvances.2024014995

Published: 2025

Includes: Supplemental data

Journal Articles

A prospective clinical trial of GVHD prophylaxis with Post-Transplant Cyclophosphamide and Abatacept

Divya Koura, Kaitlyn C. Dykes, Aaron Michael Goodman, Caitlin L. Costello, Carolyn Mulroney, James K Mangan, Tiffany N Tanaka, Edward D. Ball, Ayad Hamdan, Ah-Reum Jeong, James Mirocha, Qingyang Zhang, Paula Ogrodnik, Kimberly McConnell, Joseph J Maroge, Michelle Padilla, Gerald P Morris, Dimitrios Tzachanis

Blood Adv bloodadvances.2024015094.

https://doi.org/10.1182/bloodadvances.2024015094

Published: 2025

Includes: Supplemental data

Journal Articles

Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host disease

Husham Sharifi, Carson Tyler Moss, Zayan Musa, Alexander Bell, Christian O'Donnell, Carlos Borges, Efthymia Iliana Matthaiou, Laura Johnston, Craig Galban, Ajay Sheshadri, Gregory A Yanik, Guang-Shing Cheng, Joe L Hsu

Blood Adv bloodadvances.2025016122.

https://doi.org/10.1182/bloodadvances.2025016122

Published: 2025

Includes: Supplemental data

Journal Articles

Long-term outcomes of patients with refractory cytopenia of childhood under observation only

Beatrice Drexler, Stephan Schwarz-Furlan, Irith Baumann, Martina Rudelius, Peter Nöllke, Dirk Lebrecht, Senthilkumar Ramamoorthy, Natalia Rotari, Axel Karow, Shinsuke Hirabayashi, Fabian Beier, Yvonne Lisa Behrens, Gudrun Göhring, Reinhard Kalb, Marcin W Wlodarski, Brigitte Strahm, Miriam Erlacher, Charlotte M Niemeyer, Ayami Yoshimi

Blood Adv bloodadvances.2025016136.

https://doi.org/10.1182/bloodadvances.2025016136

Published: 2025

Includes: Supplemental data

Journal Articles

Neurocognitive gains among Ugandan children with sickle cell anemia on hydroxyurea: 18-month interim trial results

Blood Adv (2025) 9 (12): 3116–3127.

https://doi.org/10.1182/bloodadvances.2024015073

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma

Joshua N. Gustine, Andrew R. Branagan, Diana D. Cirstea, Farah Rexha, Ryan Han, Andrew J. Yee, Marcela V. Maus, Matthew J. Frigault, Noopur S. Raje

Blood Adv (2025) 9 (12): 3026–3030.

https://doi.org/10.1182/bloodadvances.2025015981

Published: 2025

Includes: Supplemental data

Journal Articles

A Phase 2 Study of Obinutuzumab Combined with Lenalidomide in Previously Untreated High Tumor Burden Follicular Lymphoma

Blood Adv bloodadvances.2025016483.

https://doi.org/10.1182/bloodadvances.2025016483

Published: 2025

Includes: Supplemental data

Journal Articles

Gene therapy for hemophilia B: results from the phase 1/2 101HEMB01/02 studies

Steven Pipe, Allen Poma, Anita Rajasekhar, Tamara Everington, Serap Sankoh, Jack Allen, Jason Cataldo, Eric Crombez

Blood Adv (2025) 9 (12): 2980–2987.

https://doi.org/10.1182/bloodadvances.2024015184

Published: 2025

Journal Articles

The impact of CMV reactivation on mortality after chimeric antigen receptor T-cell therapy

Eleftheria Kampouri, Patrick Flaherty, Hu Xie, Mandeep K. Sekhon, Clementine Chalal, Terry L. Stevens-Ayers, Damian J. Green, Jordan Gauthier, Mazyar Shadman, Ailyn C. Pérez-Osorio, Keith R. Jerome, Wendy M. Leisenring, Michael J. Boeckh, Joshua A. Hill

Blood Adv (2025) 9 (12): 2997–3001.

https://doi.org/10.1182/bloodadvances.2024015164

Published: 2025

Includes: Supplemental data

Journal Articles

Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi

Blood Adv (2025) 9 (12): 2927–2934.

https://doi.org/10.1182/bloodadvances.2024014790

Published: 2025

Includes: Supplemental data

Journal Articles

TP53-mutant variant allele frequency and cytogenetics determine prognostic groups in MDS/AML for transplantation

Konstantinos Lontos, Rima M. Saliba, Rashmi Kanagal-Shamanna, Gonca Özcan, Jeremy Ramdial, George Chen, Tapan Kadia, Nicholas James Short, Naval G. Daver, Hagop Kantarjian, David Marin, Partow Kebriaei, Uday Popat, Richard Champlin, Elizabeth Shpall, Betül Oran

Blood Adv (2025) 9 (11): 2845–2854.

https://doi.org/10.1182/bloodadvances.2024014499

Published: 2025

Journal Articles

A cure for the kiss of death?

Jacob S. Appelbaum, Mary-Elizabeth Percival, Bart L. Scott

Blood Adv (2025) 9 (11): 2855–2856.

https://doi.org/10.1182/bloodadvances.2025015850

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury

Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females

Immunological consequences of CAR T-cell therapy: an analysis of infectious complications and immune reconstitution

Younger haplo-donors improve older patient survival outcomes

Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes

Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704

Complement C5 inhibition in early onset HELLP syndrome

Efficacy and Safety of BCMA Nanobody CAR-T Cell Therapy in Relapsed or Refractory Plasma Cell Myeloma

Evaluation of In vivo CAR Transgene Levels in Tisagenlecleucel-Treated Patients with Relapsed/Refractory B-ALL and DLBCL

A prospective clinical trial of GVHD prophylaxis with Post-Transplant Cyclophosphamide and Abatacept

Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host disease

Long-term outcomes of patients with refractory cytopenia of childhood under observation only

Neurocognitive gains among Ugandan children with sickle cell anemia on hydroxyurea: 18-month interim trial results

Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma

A Phase 2 Study of Obinutuzumab Combined with Lenalidomide in Previously Untreated High Tumor Burden Follicular Lymphoma

Gene therapy for hemophilia B: results from the phase 1/2 101HEMB01/02 studies

The impact of CMV reactivation on mortality after chimeric antigen receptor T-cell therapy

Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi

TP53-mutant variant allele frequency and cytogenetics determine prognostic groups in MDS/AML for transplantation

A cure for the kiss of death?

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only